CBLL.NASDAQCeribell, INC

Form 4: Ceribell Inc. Insider Trading Activity Reported

Sentiment:

Statement of Changes in Beneficial Ownership


Xingjuan Chao, Director and President/CEO of Ceribell, Inc., reported transactions involving common stock and stock options on April 6, 2026, executed under a Rule 10b5-1 trading plan.

Summary

  • Xingjuan Chao, a key executive and director at Ceribell, Inc., has reported a series of stock transactions on April 6, 2026.
  • These transactions include the sale of 14,000 shares of common stock at a weighted average price of $18.4 per share, and the acquisition of 1,446 shares through the exercise of stock options at $4.7 per share.
  • Further sales of 1,446 shares and acquisitions of 23,554 shares via stock options were also reported.
  • The sales were conducted under a Rule 10b5-1 trading plan, designed to comply with affirmative defense conditions.
  • Following these transactions, Chao beneficially owns 850,347 shares directly and an additional 369,088 shares indirectly through the ACP 2021 Trust.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the significant sale of shares by a top executive, despite the use of a Rule 10b5-1 plan.

Positives

  • The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned and potentially defensive trading strategies.
  • Acquisition of shares through stock option exercises at a lower price ($4.7) than the sale price ($18.4) suggests a profitable exercise and sale strategy.

Negatives

  • Significant sale of 14,000 shares of common stock by a key executive and director.

Risks

  • The sale of a substantial number of shares by a director and CEO could be interpreted by the market as a lack of confidence in the company's near-term prospects, potentially impacting share price.
  • While executed under a 10b5-1 plan, the timing of sales relative to company performance or news could still be scrutinized.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports past transactions.

Management Comments

  • The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.03 to $18.77, inclusive.
  • The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
  • The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
  • The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
  • The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
  • The stock option is fully vested and currently exercisable.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan by a senior executive like Xingjuan Chao is common practice to diversify holdings or manage personal finances while mitigating concerns about insider trading.

Related Party Transactions

  • Xingjuan Chao, as a co-trustee of the ACP 2021 Trust, may share beneficial ownership of securities held by the trust.

Stakeholder Impact

  • Shareholders may view the sale of shares by the CEO and Director with caution, potentially leading to short-term share price pressure.
  • Employees may interpret the executive's stock sales as a signal about the company's future performance, though the Rule 10b5-1 plan mitigates this concern to some extent.

Next Steps

  • Continued monitoring of insider trading activity for Ceribell, Inc.
  • Analysis of future Form 4 filings to observe any further changes in beneficial ownership by key personnel.

Key Dates

DateDescription
04/01/2023Start date for monthly vesting of a portion of stock options.
04/06/2026Date of reported stock transactions (sales and option exercises).
04/08/2026Date of signature for the Form 4 filing.
02/16/2033Expiration date for certain stock options.

Recommendation

hold

The filing reports routine insider transactions under a pre-established trading plan, which limits its immediate impact on a buy/sell recommendation. While the sale of shares by a key executive warrants attention, the structured nature of the trade suggests it's not necessarily a reflection of negative fundamental outlook. Therefore, a 'hold' recommendation is appropriate pending further fundamental analysis of the company's performance and strategic direction.

Keywords

Form 4, Insider Trading, Ceribell Inc., CBLL, Xingjuan Chao, Stock Options, Rule 10b5-1, Beneficial Ownership, Common Stock, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.